BackNovo Nordisk Overview
Novo Nordisk - ADR

Novo Nordisk Target Price

See Novo Nordisk's analyst price targets ($45) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$38.8

Average Target Price

$44.6715.1% upside

3 analysts in the last 4 months

High: $47 | Low: $40

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-11Morgan StanleyThibault Boutherin$403.1% upsideOpen
2026-08-12Berenberg BankKerry Holford$4721.1% upsideOpen
2026-08-06BMO CapitalEvan Seigerman$4721.1% upsideOpen
2026-02-05BMO Capital$4516% upsideOpen
2026-01-26BMO CapitalEvan Seigerman$5746.9% upsideOpen
2025-12-10HSBC$5439.2% upsideOpen
2025-12-03Morgan StanleyThibault Boutherin$428.2% upsideOpen
2025-11-25BMO CapitalEvan Seigerman$4618.6% upsideOpen
2025-10-14BMO CapitalEvan Seigerman$5541.8% upsideOpen
2025-10-01HSBC$7080.4% upsideOpen
2025-09-29Morgan Stanley$4721.1% upsideOpen
2025-07-31HSBC$5746.9% upsideOpen
2025-07-23Truist FinancialJailendra Singh$4823.7% upsideOpen
2024-10-17BMO CapitalEvan Seigerman$156302.1% upsideOpen
2024-09-11Cantor FitzgeraldLouise Chen$160312.4% upsideOpen
2024-08-08BMO CapitalEvan David Seigerman$160312.4% upsideOpen
2024-06-10Argus ResearchJasper Hellweg$160312.4% upsideOpen
2024-05-30Goldman SachsJames Quigley$156302.1% upsideOpen
2024-04-12BMO CapitalEvan David Seigerman$163320.1% upsideOpen

Novo Nordisk (NVO) FAQ

The latest target price for NVO is $45. Investors often review this figure alongside Novo Nordisk's historical trend and sector peers before judging valuation or financial health.

Novo Nordisk trades near $38.8 while the consensus target sits at $45 (15.1% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting NVO's target price ($45), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Novo Nordisk's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.